/
ASBP
$7.15-$0.02 (-0.28%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$9.2M
1M shares
52-week range
$3.31 – $1,050.36
0% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-7384.89
Aspire Biopharma Holdings, Inc. Common Stock
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
www.aspirebiolabs.com- IPO / List date
- Feb 20, 2025
- HQ
- ESTERO, FL
Held by traders on TradeandTell
No one on the platform currently holds ASBP.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ASBP as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-05-11 | 1-for-30reverse |
| 2026-01-16 | 1-for-40reverse |
Recent trades on TradeandTell
No one on the platform has traded ASBP yet.
